Zhejiang Hichi Pharmaceutical

Zhejiang Hichi Pharmaceutical is a specialized pharmaceutical company based in Linhai, China, focused on the development and production of high-quality Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Established in 2004, the company operates within the Zhejiang Provincial Chemical Medical Raw Material Base, leveraging a strategic location for large-scale chemical synthesis. Its core product portfolio targets significant therapeutic areas, including cardiovascular diseases, viral infections, and central nervous system disorders. Notable products include intermediates for widely used drugs such as Rosuvastatin, Entecavir, and Lercanidipine. Hichi Pharmaceutical maintains rigorous quality standards, with facilities designed to meet international GMP requirements. The company serves as a key CDMO partner for global pharmaceutical firms, providing process optimization and reliable supply chain solutions.